This PhD will be a collaborative project, drawing on the expertise of Dr Andrew Fielding and Dr Morgan Gadd to develop a new small molecule to treat aggressive cancer types, in particular triple-negative breast cancer and metastatic uveal melanoma.
Dr E Parkin, Dr C Gaffney, Dr N Dawson, Dr A Benedetto
Application Deadline:
15 March 2019
An opportunity has arisen in the Division of Biomedical and Life Sciences (BLS) at Lancaster University for a talented researcher to investigate the possibility of repurposing an existing drug for the treatment of the world’s leading form of dementia, Alzheimer’s disease (AD).
University of Manchester & Lancaster University, North West Nanoscience Doctoral Training Centre. Graphene NOWNANO is a recently established Centre for Doctoral Training (CDT) at the University of Manchester in partnership with Lancaster University.
